94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Brie Chun; Joanna Pucilowska; Shu Ching Chang; Isaac Kim; Benjamin Nikitin; Yoshinobu Koguchi; William Redmond; Brady Bernard; Venkatesh Rajamanickam; Nathan Polaske; Paul Fields; Valerie Conrad; Mark Schmidt; Walter Urba; Alison Conlin; Heather McArthur; David Page

doi:10.1136/jitc-2021-SITC2021.094

Article info

Regular and Young Investigator Award Abstracts

Biomarkers, Immune Monitoring, and Novel Technologies

94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Free

Authors

Brie Chun EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Joanna Pucilowska EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Shu Ching Chang Providence St. Joseph Health, Portland, OR, USA PubMed articles Google scholar articles
Isaac Kim EACRI, Providence Cancer Center, Portland, OR, USA PubMed articles Google scholar articles
Benjamin Nikitin EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Yoshinobu Koguchi EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
William Redmond EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Brady Bernard EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Venkatesh Rajamanickam EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Nathan Polaske Adaptive Biotechnologies, Seattle, WA, USA PubMed articles Google scholar articles
Paul Fields Adaptive Biotechnologies, Seattle, WA, USA PubMed articles Google scholar articles
Valerie Conrad EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Mark Schmidt EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Walter Urba EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Alison Conlin EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles
Heather McArthur Cedars-Sinai Medical Center, Los Angeles, CA, USA PubMed articles Google scholar articles
David Page EACRI, Providence Cancer Institute, Portland, OR, USA PubMed articles Google scholar articles

Citation

Chun B, Pucilowska J, Chang SC, et al

94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.094

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password